P53 Mdm2 Inhibitors

Author(s): Kareem Khoury, Alex Domling

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 30 , 2012

Become EABM
Become Reviewer


The protein-protein interaction (PPI) between p53 and its negative regulator MDM2 comprises one of the most important and intensely studied PPI's involved in preventing the initiation of cancer. The interaction between p53 and MDM2 is conformation-based and is tightly regulated on multiple levels. Due to the Angstrom level structural insight there is a reasonable understanding of the structural requirements needed for a molecule to bind to MDM2 and successfully inhibit the p53/MDM2 interaction. The current review summarizes the binding characteristics of the different disclosed small molecules for inhibition of MDM2 with a co-crystal structure. Synthetic access to these compounds as well as their derivatives are described in detail.

Keywords: p53, MDM2, HDM2, protein protein interactions, small molecule inhibitors, negative regulator, cancer, Angstrom level, p53/MDM2 interaction, derivatives.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [4668 - 4678]
Pages: 11
DOI: 10.2174/138161212802651580
Price: $65

Article Metrics

PDF: 20